Shifts in the fecal microbiota associated with adenomatous polyps

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 1, 2017, Pages 85-94

  Hale, Vanessa L ^a,b   Chen, Jun ^a   Johnson, Stephen ^a   Harrington, Sean C ^b   Yab, Tracy C ^a   Smyrk, Thomas C ^a   Nelson, Heidi ^a   Boardman, Lisa A ^a   Druliner, Brooke R ^a   Levin, Theodore R ^c   Rex, Douglas K ^d   Ahnen, Dennis J ^e   Lance, Peter ^f   Ahlquist, David A ^a   Chia, Nicholas ^a,b,g  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (Germany)

^c KAISER PERMANENTE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

^g MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; DEXTRO ALANINE; LIPID; NICOTINAMIDE; NICOTINIC ACID; PURINE; PYRIMIDINE; RNA 16S; STARCH; SUCROSE;

ACTINOBACTERIA; ADENOMATOUS POLYP; AGED; ARTICLE; BACTEROIDETES; BILE ACID SYNTHESIS; BILOPHILA; COLONOSCOPY; COLORECTAL CANCER; DELTAPROTEOBACTERIA; DESULFOVIBRIO; FECES MICROFLORA; FEMALE; FIRMICUTES; GENE SEQUENCE; HAEMOPHILUS; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MOGIBACTERIUM; PRIORITY JOURNAL; RANDOM FOREST; SPECIES RICHNESS; SPHINGOLIPID METABOLISM; SUTTERELLA; VEILLONELLA; CASE CONTROL STUDY; CLINICAL TRIAL; COLON POLYP; COLORECTAL TUMOR; COMPARATIVE STUDY; FECES; GENETICS; INTESTINE FLORA; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PRECANCER; PROCEDURES; PROGNOSIS; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPECIMEN HANDLING; VERY ELDERLY;

ADENOMATOUS POLYPS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RNA, RIBOSOMAL, 16S; SPECIMEN HANDLING;

EID: 85009115821     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-16-0337     Document Type: Article

References (78)

1. Fenoglio CM, Lane N. The anatomical precursor of colorectal carcinoma. Cancer 1974;34:819-23.
2. Leslie A, Carey FA, Pratt NR, Steele RJC. The colorectal adenoma-carcinoma sequence. Br J Surg 2002;89:845-60.
3. American Cancer Society. Colorectal cancer facts & figures 2014-2016; 2014. Available from: http://www.cancer.org/acs/groups/content/documents/document/acspc-042280.pdf
4. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, et al. Colonoscopic polypectomy and long-Term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687-96.
5. Atkin WS, Morson BC, Cuzick J. Long-Term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658-62.
6. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy.NEngl J Med 1993;329:1977-81.
7. Chao A, Thun MJ, Jacobs EJ, Henley SJ, Rodriguez C, Calle EE. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst 2000;92:1888-96.
8. Bouvard V, Loomis D, Guyton KZ, Grosse Y, Ghissassi FE, Benbrahim-Tallaa L, et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol 2015;16:1599-600.
9. Fedirko V, Tramacere I, Bagnardi V, RotaM, Scotti L, Islami F, et al. Alcohol drinking and colorectal cancer risk: An overall and dose-response metaanalysis of published studies. Ann Oncol 2011;22:1958-72.
10. Slattery ML. Physical activity and colorectal cancer. Sports Med 2012;34: 239-52.
11. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 2014;12:661-72.
12. Dulal S, Keku TO. Gut microbiome and colorectal adenomas. Cancer J 2014;20:225-31.
13. Sonnenburg JL, Fischbach MA.Community health care: Therapeutic opportunities in the human microbiome. Sci Transl Med 2011;3:78ps12.
14. O'Keefe SJD, Li JV, Lahti L, Ou J, Carbonero F, Mohammed K, et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun 2015;6:6342.
15. Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut 2013;62:933-47.
16. Chen J, Bittinger K, Charlson ES, Hoffmann C, Lewis J, Wu GD, et al. Associatingmicrobiome compositionwith environmental covariates using generalized UniFrac distances. Bioinform 2012;28:2106-13.
17. Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS ONE 2013;8:e70803.
18. Langille MGI, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotech 2013;31:814-21.
19. Wagner Mackenzie B, Waite DW, Taylor MW. Evaluating variation in human gut microbiota profiles due to DNA extraction method and inter-subject differences. Front Microbiol 2015;6:130.
20. Jeraldo P, Chia N, Goldenfeld N. On the suitability of short reads of 16S rRNA for phylogeny-based analyses in environmental surveys. Environ Microbiol 2011;13:3000-9.
21. Sinha R, Chen J, Amir A, Vogtmann E, shi J, Inman KS, et al. Collecting fecal samples for microbiome analyses in epidemiology studies. Cancer Epidemiol Biomark Prev 2016;25:407-16.
22. Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008;149:441-50.
23. Baldwin EA, Walther-Antonio M, MacLean AM, Gohl DM, Beckman KB, Chen J, et al. Persistentmicrobial dysbiosis in preterm premature rupture of membranes from onset until delivery. PeerJ 2015;3:e1398.
24. Jeraldo P, Kalari K, Chen X, Bhavsar J, Mangalam A, White B, et al. IMTORNADO: A tool for comparison of 16S reads from paired-end libraries. PLoS ONE 2014;9:e114804.
25. Zhao N, Chen J, Carroll Ian M, Ringel-Kulka T, Epstein Michael P, Zhou H, et al. Testing in microbiome-profiling studies with MiRKAT, the microbiome regression-based kernel association test.AmJHumGenet 2015;96:797-807.
26. Aagaard K, Petrosino J, Keitel W, WatsonM, Katancik J, Garcia N, et al. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J 2013;27:1012-22.
27. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012;486:207-14.
28. Breiman L. Random forests. Mach Learn 2001;45:5-32.
29. Kursa MB, Rudnicki WR. Feature selection with the boruta package. J Stat Softw 2010;36:1-13.
30. Efron B, Tibshirani R. Improvements on cross-validation: The .632 bootstrap method. J Am Stat Assoc 1997;92:548-60.
31. Warren YA, Citron DM, Merriam CV, Goldstein EJC. Biochemical differentiation and comparison of Desulfovibrio species and Other phenotypically similar genera. J Clin Microbiol 2005;43:4041-5.
32. Baron EJ. Bilophila. Bergey's Manual of Systematics of Archaea and Bacteria: John Wiley & Sons, Ltd; 2015. DOI: 10.1002/9781118960608.gbm01034.
33. Attene-Ramos MS, Nava GM, Muellner MG, Wagner ED, Plewa MJ, Gaskins HR. DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells. Environ Mol Mutagen 2010; 51:304-14.
34. Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-Associated microbiota in patients with colorectal cancer. PLoS ONE 2012;7:e39743.
35. Yazici C, Wolf PG, Carroll TP, Mutlu E, Xicola RM, Llor X, et al. 511 Bilophila wadsworthia is more abundant in the colonic microbiome of colorectal cancer cases compared to healthy controls. Gastroenterol 2015;148:S-100.
36. Brim H, Yooseph S, Zoetendal EG, Lee E, Torralbo M, Laiyemo AO, et al. Microbiome analysis of stool samples from African Americans with colon polyps. PLoS ONE 2013;8:e81352.
37. Chen H-M, Yu Y-N, Wang J-L, Lin Y-W, Kong X, Yang C-Q, et al. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am J Clin Nutr 2013;97:1044-52.
38. Wu N, Yang X, Zhang R, Li J, Xiao X, Hu Y, et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol 2013;66:462-70.
39. Zackular JP, Baxter NT, Iverson KD, SadlerWD, Petrosino JF, Chen GY, et al. The gut microbiome modulates colon tumorigenesis. mBio 2013;4:13.
40. Shen XJ, Rawls JF, Randall T, Burcal L, Mpande CN, Jenkins N, et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 2010;1:138-47.
41. Kostic AD, Chun E, Meyerson M, Garrett WS. Microbes and inflammation in colorectal cancer. Cancer Immunol Res 2013;1:150157.
42. Candela M, Turroni S, Biagi E, Carbonero F, Rampelli S, Fiorentini C, et al. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol 2014;20:908-22.
43. Nakazawa F, Sato M, Poco SE, Hashimura T, Ikeda T, Kalfas S, et al. Description of Mogibacterium pumilum gen. nov., sp. nov. and Mogibacterium vescum gen. nov., sp. nov., and reclassification of Eubacteriumtimidum (Holdeman et al. 1980) as Mogibacterium timidum gen. nov., comb. nov. Intl J Syst Evol Microbiol 2000;50:679-88.
44. Casarin RCV, Saito D, Santos VR, Pimentel SP, Duarte PM, Casati MZ, et al. Detection of Mogibacteriumtimidum in subgingival biofilm of aggressive and non-diabetic and diabetic chronic periodontitis patients. Braz JMicrobiol 2012;43:931-7.
45. Rooks MG, Veiga P, Wardwell-Scott LH, Tickle T, Segata N, Michaud M, et al. Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J 2014;8:1403-17.
46. Steinhart CE, Doyle ME, Cochrane BA. Food Safety 1995. New York, NY: Marcel Dekker, Inc.; 1995.
47. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011;469:543-7.
48. McCoy AN, Araujo-Perez F, Azcarate-Peril A, Yeh JJ, Sandler RS, Keku TO. Fusobacterium is associated with colorectal adenomas. PLoS ONE 2013;8: e53653.
49. Mira-Pascual L, Cabrera-Rubio R, Ocon S, Costales P, Parra A, Suarez A, et al. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol 2014;50:167-79.
50. Hale VL, Tan CL, Knight R, Amato KR. Effect of preservation method on spider monkey (Ateles geoffroyi) fecal microbiota over 8 weeks. J Microbiol Methods 2015;113:1626.
51. Jones MB, Highlander SK, Anderson EL, Li W, Dayrit M, Klitgord N, et al. Library preparation methodology can influence genomic and functional predictions in human microbiome research. Proc Natl Acad Sci USA 2015;112:14024-9.
52. Hamady M, Knight R. Microbial community profiling for human microbiome projects: Tools, techniques, and challenges. Genome Res 2009; 19:1141-52.
53. ClooneyAG, Fouhy F, Sleator RD, O' Driscoll A, Stanton C, Cotter PD, et al. Comparing apples and oranges? next generation sequencing and its impact on microbiome analysis. PLoS ONE 2016;11:e0148028.
54. Choi S, Snider AJ. Sphingolipids in high fat diet and obesity-related diseases. Mediat Inflam 2015;2015:12.
55. Rampelli S, Schnorr Stephanie L, Consolandi C, Turroni S, Severgnini M, Peano C, et al. Metagenome sequencing of the Hadza hunter-gatherer gut microbiota. Curr Biol 2015;25:1682-93.
56. Russell WR, Duncan SH, Scobbie L, Duncan G, Cantlay L, Calder AG, et al. Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein. Mol Nutr Food Res 2013;57: 523-35.
57. Reddy BS. Diet and excretion of bile acids. Cancer Res 1981;41:3766-8.
58. Makambi KH, Agurs-Collins T, Bright-Gbebry M, Rosenberg L, Palmer JR, Adams-Campbell LL. Dietary patterns and the risk of colorectal adenomas: The Black women's health study. Cancer Epidemiol Biomark Prev 2011;20: 818-25.
59. Wu K, Hu FB, Fuchs C, Rimm EB, Willett WC, Giovannucci E. Dietary patterns and risk of colon cancer and adenoma in a cohort of men (United States). Cancer Causes Control 2004;15:853-62.
60. Giovannucci E, Stampfer MJ, Colditz G, Rimm EB, Willett WC. Relationship of diet to risk of colorectal adenoma in men. J Natl Cancer Inst 1992;84:91-8.
61. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice. Nat 2012;487:104-8.
62. Ridlon JM, Wolf PG, Gaskins HR. Taurocholic acid metabolism by gut microbes and colon cancer. Gut Microbes 2016;7:201-15.
63. Nagengast FM, GrubbenMJ, van Munster IP. Role of bile acids in colorectal carcinogenesis. Eur J Cancer 1995;31A:1067-70.
64. Bernstein C, Holubec H, Bhattacharyya AK, Nguyen H, Payne CM, Zaitlin B, et al. Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol 2011;85:863-71.
65. Payne CM, Bernstein C, Dvorak K, Bernstein H. Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis. Clin Exp Gastroenterol 2008;1:19-47.
66. Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol 2009;15: 3329-40.
67. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-Associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-131.
68. Okabayashi K, AshrafianH, Hasegawa H, Yoo J-H, Patel VM, Harling L, et al. Body mass index category as a risk factor for colorectal adenomas: A systematic reviewandmeta-Analysis.AmJGastroenterol2012;107:1175-85.
69. FerrerM, Ruiz A, Lanza F, Haange S-B, Oberbach A, Till H, et al. Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure. Environ Microbiol 2013;15:211-26.
70. Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-Term impacts of antibiotic exposure on the human intestinal microbiota. Microbiol 2010; 156:3216-23.
71. Zackular JP, Rogers MAM, Ruffin MT, Schloss PD. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res 2014;7:1112-21.
72. Goedert JJ, Gong Y, Hua X, Zhong H, He Y, Peng P, et al. Fecal microbiota characteristics of patients with colorectal adenoma detected by screening: A population-based study. EBioMed 2015;2:597-603.
73. Choo JM, Leong LEX, Rogers GB. Sample storage conditions significantly influence faecal microbiome profiles. Sci Rep 2015;5:16350.
74. Carroll IM, Ringel-Kulka T, Siddle JP, Klaenhammer TR, Ringel Y. Characterization of the fecal microbiota using high-Throughput sequencing reveals a stable microbial community during storage. PLoS ONE 2012;7: e46953.
75. Ringel Y, Maharshak N, Ringel-Kulka T, Wolber EA, Sartor RB, Carroll IM. High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals. Gut Microbes 2015;6:173-81.
76. Scanlan PD, Shanahan F, Clune Y, Collins JK, O'Sullivan GC, O'Riordan M, et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 2008;10:789-98.
77. Sanapareddy N, Legge RM, Jovov B, McCoy A, Burcal L, Araujo-Perez F, et al. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J 2012;6:1858-68.
78. Nugent JL, McCoy AN, Addamo CJ, Jia W, Sandler RS, Keku TO, et al. Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenoma. J Proteome Res 2014;13:1921-29.